Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/26 16:01 | 5/1/26 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | 5 | S.dm | -473 | 19.06 | 0 | -25 | 38 | D | ||||||||||||||||
6/17/26 20:47 | 6/15/26 | ARQT | Health | Drug | Pharmaceutical Preparations | Lin Sue-Jean | CA | D | 1 | S | -121 | 24.38 | 0 | -5 | 28 | D | ||||||||||||||||
5/13/26 19:43 | 5/11/26 | ARQT | Health | Drug | Pharmaceutical Preparations | Vairavan Latha | CA | O | SVP CFO | 2 | S | -41 | 22.98 | 0 | -2 | 86 | D | |||||||||||||||
5/13/26 19:42 | 5/11/26 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | 2 | S | -21 | 22.98 | 0 | -1 | 120 | D | |||||||||||||||
5/6/26 19:40 | 5/4/26 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | 1 | S | -192 | 23.31 | 0 | -8 | 127 | D | |||||||||||||||
5/6/26 18:06 | 5/4/26 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | 1 | S | -75 | 23.61 | 0 | -3 | 0 | 954 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |